]>
IRCT20130812014333N161 IRCT 2021-03-08 Kermanshah University of Medical Sciences The effect of omega-3 fatty acids in the treatment of patients with mood disorders caused by methamphetamine Evaluation of the effectiveness of omega-3 fatty acid supplementation compared with placebo in the treatment of patients with mood disorders caused by methamphetamine 2021-03-05 anticipated 50 Complete https://irct.ir/trial/53974 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Using the random number table, patients will be divided into two groups of 25. Each patient will be assigned a 4-digit code based on the random number table, Based on the right number of patients' code, the patients will be divided into two groups. Patients whose last digit is 0, 2, 4, 6, 8 will be assigned to the intervention group and patients whose last digit is 1,3,5, 7, 9 will be assigned to the control group, Blinding description: In this double-blinded study, the researcher and the patient do not know who will receive the new drug. Patients will be aware of the participation in the study, but the researcher and the participant will be kept blinded to which group will receive the new medicine and which group will receive the placebo. The placebo and the new drug are both in the same capsule form, kept in the same container. Drugs can only be identified by the serial number on the container. 2-3 Condition 1: Mood disorders. Condition 2: Methamphetamine Dependency. Intervention 1: The intervention group,in addition to standard treatment, will receive 30 capsules containing 1 gram of omega-3 for 8 weeks (1 capsule daily). Intervention 2: The control group, in addition to standard treatment, will receive 30 capsules containing 1 gram of placebo for 8 weeks (1 capsule daily). No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no more information
public Nona Vaezi
Isar Square, Dolatabad Boulevard, Farabi Hospital
Kermanshah Iran (Islamic Republic of) 6715847141 +98 83 3826 1046 Amirvaezi007@yahoo.com Kermanshah University of Medical Sciences scientific Dr. Faezeh Tatari
Isar Square, Dolatabad Boulevard, Farabi Hospital
Kermanshah Iran (Islamic Republic of) 6715847141 +98 83 3826 1046 fztatari37@gmail.com Kermanshah University of Medical Sciences Iran (Islamic Republic of) Diagnosis of methamphetamine-induced mood disorders based on DSM5 diagnostic criteria no limit no limit Both Simultaneous use of other substances History of primary mood disorders History of brain disorders People with certain diseases and kidney patients People with blood clotting problems F31.32 F15.15 Bipolar disorder, current episode depressed, moderate Other stimulant abuse with stimulant-induced psychotic disorder Treatment - Drugs Treatment - Other The intervention group,in addition to standard treatment, will receive 30 capsules containing 1 gram of omega-3 for 8 weeks (1 capsule daily). The control group, in addition to standard treatment, will receive 30 capsules containing 1 gram of placebo for 8 weeks (1 capsule daily). Recurrence rate. Timepoint: Beginning of the study, end of the fourth week, end of the eighth week. Method of measurement: Based on recurrence questionnaire (RPS). Temptation. Timepoint: Beginning of the study, end of the fourth week, end of the eighth week. Method of measurement: Based on the temptation questionnaire. Kermanshah University of Medical Sciences Approved 2020-11-10 Ethics committee of Kermanshah University of Medical Sciences Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences, Building No.2, Shahid Beheshti Boulevard Kermanshah Kermanshah Iran (Islamic Republic of)